We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

153 hedge funds and large institutions have $198M invested in Clovis Oncology, Inc. in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 27

3% less funds holding

Funds holding: 157 → 153 (-4)

28% less call options, than puts

Call options by funds: $4.29M | Put options by funds: $5.93M

32% less capital invested

Capital invested by funds: $292M → $198M (-$94.4M)

Holders
153
Holders Change
-4
Holders Change %
-2.55%
% of All Funds
2.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
54
Reduced
39
Closed
27
Calls
$4.29M
Puts
$5.93M
Net Calls
-$1.65M
Net Calls Change
-$874K

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$5.35M
2
State Street
State Street
Massachusetts
+$5.32M
3
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.29M
4
Citigroup
Citigroup
New York
+$2.06M
5
QF
QVT Financial
New York
+$1.87M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$8.06M
2
Morgan Stanley
Morgan Stanley
New York
-$2.48M
3
PAI
Palo Alto Investors
California
-$1.8M
4
Principal Financial Group
Principal Financial Group
Iowa
-$914K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$739K
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
101
Paloma Partners
Connecticut
$55K +$75.2K +20,336 New
WS
102
Wedbush Securities
California
$54K -$20.3K -5,500 -22%
AB
103
Amalgamated Bank
New York
$54K -$713 -193 -1%
STB
104
S&T Bank
Pennsylvania
$54K – – –
MCM
105
MAI Capital Management
Ohio
$54K +$37K +10,000 +100%
Victory Capital Management
106
Victory Capital Management
Texas
$48K +$3.98K +1,078 +6%
MLICM
107
Metropolitan Life Insurance Company (MetLife)
New York
$46K +$8.45K +2,285 +16%
EGM
108
Engineers Gate Manager
New York
$45K +$62K +16,779 New
DT
109
Diversified Trust
Tennessee
$44K – – –
Ameriprise
110
Ameriprise
Minnesota
$42K -$7.89K -2,135 -12%
AFG
111
Allegheny Financial Group
Pennsylvania
$41K -$2.77K -750 -5%
CSS
112
Cubist Systematic Strategies
Connecticut
$40K -$7.64K -2,067 -12%
CA
113
Cetera Advisors
Colorado
$38K +$51.9K +14,030 New
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$36K – – –
SPC
115
Sigma Planning Corp
Michigan
$36K +$49K +13,249 New
NSEDCP
116
NJ State Employees Deferred Compensation Plan
New Jersey
$35K – – –
CBB
117
Citizens Business Bank
California
$33K +$44.4K +12,000 New
PAMS
118
Pictet Asset Management (Switzerland)
Switzerland
$29K – – –
SSA
119
Schonfeld Strategic Advisors
New York
$28K +$38.1K +10,300 New
EW
120
Evoke Wealth
California
$27K – – –
SFG
121
SNS Financial Group
Minnesota
$27K – – –
AIP
122
Ameritas Investment Partners
Nebraska
$21K – – –
Public Employees Retirement Association of Colorado
123
Public Employees Retirement Association of Colorado
Colorado
$21K – – –
ACM
124
Antonetti Capital Management
Florida
$20K -$11.8K -3,200 -30%
NFSG
125
Newbridge Financial Services Group
Florida
$18K – – –
3 4
5
6 7

CLVS Hedge Fund Activity: Q4 2021 in Review

153 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2021, worth a combined $198M — down 32% from $292M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of CLVS and 26 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 54 added.

The largest buyer was Bank of America, adding an estimated $5.35M. The largest seller was Vanguard Group, cutting an estimated $8.06M.

  • 153 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2021, down from 157 in Q3 2021.
  • Funds reported $198M of Clovis Oncology, Inc. stock for Q4 2021, down 32% quarter-over-quarter.
  • 26 funds opened new Clovis Oncology, Inc. positions in Q4 2021 and 27 closed out, a net change of -1 holder.
  • The largest Clovis Oncology, Inc. buyer in Q4 2021 was Bank of America, an estimated $5.35M added.
  • The largest Clovis Oncology, Inc. seller in Q4 2021 was Vanguard Group, an estimated $8.06M sold.

Based on aggregated 13F filings for Q4 2021.